EMA — authorised 14 January 2015
- Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
- Status: approved
🇪🇺 Cosentyx in European Union
EMA authorised Cosentyx on 14 January 2015
Marketing authorisation
Cosentyx in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Cosentyx approved in European Union?
Yes. EMA authorised it on 14 January 2015.
Who is the marketing authorisation holder for Cosentyx in European Union?
NOVARTIS EUROPHARM LIMITED holds the EU marketing authorisation.